SITC 2021 | Proteomic markers after injections of AV-GBM-1

Daniela Bota, MD, PhD, The University of California, Irvine, Irvine, CA, explains the injection of the AV-GBM-1 vaccine, which consists of dendritic cells plus granulocyte-macrophage colony-stimulating factor (GM-CSF), and discusses the proteomic markers following injection. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.